.
New Delhi, April 21 (MondayMirror.com) The expert panel of India’s apex drug regulator on Thursday recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.
According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E’s Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.
Earlier in the day, the panel held a meeting to discuss the recommendations on restricted emergency use of Bharat Biotech’s Covaxin and Biological E’s Corbevax vaccines among children aged 5-12.
The SEC has sent the recommendations to the DCGI. After the DCGI’s nod to the recommendation, the Union Health Ministry may give final approval to begin the vaccination for this age group.
Corbevax vaccine is India’s first indigenously-developed protein sub-unit vaccine against Covid-19. This vaccine is currently being administered to children in the age group 12-14 years.
Source: IANS
The way Bollywood promotes films has undergone a remarkable transformation over the past decade. Earlier,…
The Bollywood film industry has experienced a significant transformation in how success is measured. For…
Highlighting the growing role of women in leadership, Rotary Club Chandigarh Midtown (District 3080) witnessed…
Bollywood has always fascinated audiences with its larger-than-life stories, glamorous stars, breathtaking locations, and memorable…
The way Bollywood promotes its films has changed dramatically over the past decade. There was…
The definition of success in Bollywood has changed dramatically over the past decade. There was…